Related Experiment Video
Updated: Jul 19, 2025

06:08
Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
1.8K
Distinction between rhinitis alone and rhinitis with asthma using interactomics
Daniel Aguilar1, Nathanaël Lemonnier2, Erik Melén3,4
16AM Data Mining, Barcelona, Spain.
Scientific Reports
|August 12, 2023
Summary
The "one-airway-one-disease" concept is challenged by new findings. Allergic rhinitis alone and with asthma involve distinct molecular pathways, suggesting they are separate conditions.
Area of Science:
- Immunology
- Genomics
- Systems Biology
Background:
- The
- one-airway-one-disease
- concept suggests allergic diseases are linked.
- Genomic studies indicate distinct pathways for rhinitis alone versus rhinitis with asthma.
Purpose of the Study:
- To differentiate molecular mechanisms of allergic rhinitis alone and in multimorbidity with asthma using human interactome data.
- To investigate differences in pathway topology and associated biological processes between these two phenotypes.
Main Methods:
- Utilized human interactome data within the MeDALL (Mechanisms of the Development of Allergy) study.
- Analyzed and compared molecular pathways and network topology for rhinitis alone and rhinitis with asthma multimorbidity phenotypes.
Main Results:
- Significant differences observed in interactome topology and associated pathways between the two phenotypes.
- Rhinitis alone pathways: cell cycle, cytokine signalling, developmental biology, immune system, protein metabolism, signal transduction. Toll-like receptors and IL-17 signalling identified.
- Rhinitis with asthma pathways: predominantly signal transduction, with some cytokine signalling, immune system, and developmental biology. IL-33 identified.
Conclusions:
- Rhinitis alone and rhinitis with asthma multimorbidity exhibit distinct molecular mechanisms and pathway associations.
- These findings challenge the
- one-airway-one-disease
- concept, supporting the classification of these conditions as separate diseases.
Related Concept Videos
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma: Pathogenesis and Management
446
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
446
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
346
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
346
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K

